Contributor Disclosures for Fabry Disease
Role Name Disclosure Details
Author Zuzana Baranova, MD, PhD, Senior Lecturer, Department of Dermatology, University of PJ Safarik at Kosice, Slovak Republic Nothing to discloseDetails
Coauthor Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School Nothing to discloseDetails
Coauthor Janette Baloghova, MD, PhD, Lecturer, Department of Dermatology, Medical Faculty, University of PJ Safarik at Kosice, Slovak Republic Nothing to discloseDetails
Coauthor Alexander Halagovec, MD, PhD, Professor, Department of Dermatology, PJ Safarik University School of Medicine, Slovakia Republic Nothing to discloseDetails
Medical Editor Jacek C Szepietowski, MD, PhD, Professor and Vice-Head, Department of Dermatology, Venereology and Allergology, University of Medicine at Wroclaw, Poland Nothing to discloseDetails
Pharmacy Editor David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic Nothing to discloseDetails
Managing Editor Warren R Heymann, MD, Head, Division of Dermatology, Professor, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey Nothing to discloseDetails
CME Editor Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University Nothing to discloseDetails
Chief Editor William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System elsevierDetails

eMedicine Code of Ethics
    1. eMedicine.com, Inc, henceforth referred to as eMedicine, is dedicated to providing up-to-date, peer-reviewed medical information. This information may be accessed in various ways; however, the primary delivery portal is the Internet. The free availability of our medical journals online reflects the commitment of eMedicine to disseminate knowledge to the widest possible audience, including individuals, groups, or populations that may not otherwise have access to such medical information.

    2. eMedicine is committed to publishing medical journals of high quality. To achieve this end, all eMedicine topics are reviewed and edited by 4 physicians and a doctor of pharmacy. eMedicine strives to ensure that any claims relating to the benefits of a specific treatment, commercial product, or service are supported by appropriate, balanced evidence. Therefore, each article contains references to sources used when writing the topic and the date when clinical information was last modified.

    3. eMedicine respects and values the sanctity of the physician-patient relationship. Information provided by eMedicine is designed to support, not replace, the relationships that exist among patients and their physicians and other health care providers. Accordingly, eMedicine's authors and editors do not provide patient consultation through email.

    4. eMedicine's owners, staff, authors, editors, and advertisers maintain the confidentiality of the identity of individual patients whose cases may be presented and that of visitors to the eMedicine Web site.

    5. eMedicine is a privately held organization. Advertising by commercial and noncommercial organizations that provide funding, services, or materials for eMedicine activities does not influence medical content. eMedicine's advertising and promotional material is subject to review by the Ethics Committee and is presented to viewers in a manner and context that facilitates differentiation between the advertising and promotional material and the original textual information.

    6. eMedicine does not endorse any medical institution, biomedical technology, or pharmaceutical product. Furthermore, eMedicine requires authors to report any conflict of interest (eg, financial interest in any medical companies, pharmaceutical company funding of topic-related research) and posts such disclosures in each article.


    For further information, contact Lynn Barkley Burnett, EdD, MS, Chair, eMedicine Ethics Committee.









Contributor Disclosure


Contributor:
Contributor Disclosure:
Zuzana Baranova, Author  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Robert A Schwartz

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Janette Baloghova, Coauthor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Alexander Halagovec, MD, PhD, Coauthor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Jacek C Szepietowski, Medical Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
David F Butler

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Warren R Heymann, Managing Editor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Catherine Quirk, CME Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
William D James

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

elsevier
RoyaltyOther 
Off label or investigational use of medication